308 related articles for article (PubMed ID: 34663867)
1. Optogenetic stimulation of lateral hypothalamic orexin/dynorphin inputs in the ventral tegmental area potentiates mesolimbic dopamine neurotransmission and promotes reward-seeking behaviours.
Thomas CS; Mohammadkhani A; Rana M; Qiao M; Baimel C; Borgland SL
Neuropsychopharmacology; 2022 Feb; 47(3):728-740. PubMed ID: 34663867
[TBL] [Abstract][Full Text] [Related]
2. Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction.
Aston-Jones G; Smith RJ; Sartor GC; Moorman DE; Massi L; Tahsili-Fahadan P; Richardson KA
Brain Res; 2010 Feb; 1314():74-90. PubMed ID: 19815001
[TBL] [Abstract][Full Text] [Related]
3. Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area.
Muschamp JW; Hollander JA; Thompson JL; Voren G; Hassinger LC; Onvani S; Kamenecka TM; Borgland SL; Kenny PJ; Carlezon WA
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):E1648-55. PubMed ID: 24706819
[TBL] [Abstract][Full Text] [Related]
4. Blockade of orexin-1 receptors in the ventral tegmental area could attenuate the lateral hypothalamic stimulation-induced potentiation of rewarding properties of morphine.
Zarepour L; Fatahi Z; Sarihi A; Haghparast A
Neuropeptides; 2014 Jun; 48(3):179-85. PubMed ID: 24793540
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction between OX2 and CB1 receptors in the ventral tegmental area and the nucleus accumbens in response to place preference induced by chemical stimulation of the lateral hypothalamus.
Yazdi F; Jahangirvand M; Pirasteh AH; Moradi M; Haghparast A
Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):39-46. PubMed ID: 26494513
[TBL] [Abstract][Full Text] [Related]
6. Lateral hypothalamic orexin glucose-inhibited neurons may regulate reward-based feeding by modulating glutamate transmission in the ventral tegmental area.
Teegala SB; Sheng Z; Dalal MS; Hirschberg PR; Beck KD; Routh VH
Brain Res; 2020 Mar; 1731():145808. PubMed ID: 29787770
[TBL] [Abstract][Full Text] [Related]
7. Brain site-specific regulation of hedonic intake by orexin and DYN peptides: role of the PVN and obesity.
Mattar P; Uribe-Cerda S; Pezoa C; Guarnieri T; Kotz CM; Teske JA; Morselli E; Perez-Leighton C
Nutr Neurosci; 2022 May; 25(5):1105-1114. PubMed ID: 33151127
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory Input from the Lateral Hypothalamus to the Ventral Tegmental Area Disinhibits Dopamine Neurons and Promotes Behavioral Activation.
Nieh EH; Vander Weele CM; Matthews GA; Presbrey KN; Wichmann R; Leppla CA; Izadmehr EM; Tye KM
Neuron; 2016 Jun; 90(6):1286-1298. PubMed ID: 27238864
[TBL] [Abstract][Full Text] [Related]
9. Orexin Signaling in the VTA Gates Morphine-Induced Synaptic Plasticity.
Baimel C; Borgland SL
J Neurosci; 2015 May; 35(18):7295-303. PubMed ID: 25948277
[TBL] [Abstract][Full Text] [Related]
10. Orexin/hypocretin role in reward: implications for opioid and other addictions.
Baimel C; Bartlett SE; Chiou LC; Lawrence AJ; Muschamp JW; Patkar O; Tung LW; Borgland SL
Br J Pharmacol; 2015 Jan; 172(2):334-48. PubMed ID: 24641197
[TBL] [Abstract][Full Text] [Related]
11. Projection-Target-Defined Effects of Orexin and Dynorphin on VTA Dopamine Neurons.
Baimel C; Lau BK; Qiao M; Borgland SL
Cell Rep; 2017 Feb; 18(6):1346-1355. PubMed ID: 28178514
[TBL] [Abstract][Full Text] [Related]
12. Disinhibition of Mesolimbic Dopamine Circuit by the Lateral Hypothalamus Regulates Pain Sensation.
Ma Y; Zhao W; Chen D; Zhou D; Gao Y; Bian Y; Xu Y; Xia SH; Fang T; Yang JX; Song L; Liu H; Ding HL; Zhang H; Cao JL
J Neurosci; 2023 Jun; 43(24):4525-4540. PubMed ID: 37188517
[TBL] [Abstract][Full Text] [Related]
13. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
14. Role of lateral hypothalamic orexin neurons in reward processing and addiction.
Aston-Jones G; Smith RJ; Moorman DE; Richardson KA
Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):112-21. PubMed ID: 18655797
[TBL] [Abstract][Full Text] [Related]
15. Lateral hypothalamic orexin/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference.
Richardson KA; Aston-Jones G
J Neurosci; 2012 Mar; 32(11):3809-17. PubMed ID: 22423101
[TBL] [Abstract][Full Text] [Related]
16. Chemical stimulation of the lateral hypothalamus induced seeking behaviors in rats: Involvement of orexin receptors in the ventral tegmental area.
Mahmoudi M; Maleki-Roveshti M; Karimi-Haghighi S; Haghparast A
Eur J Pharmacol; 2020 Nov; 886():173433. PubMed ID: 32763297
[TBL] [Abstract][Full Text] [Related]
17. Optogenetic stimulation of dynorphinergic neurons within the dorsal raphe activate kappa opioid receptors in the ventral tegmental area and ablation of dorsal raphe prodynorphin or kappa receptors in dopamine neurons blocks stress potentiation of cocaine reward.
Abraham AD; Casello SM; Land BB; Chavkin C
Addict Neurosci; 2022 Mar; 1():. PubMed ID: 36176476
[TBL] [Abstract][Full Text] [Related]
18. A Review of the Physiological Role of Hypocretin in the Ventral Tegmental Area in Reward and Drug Dependence.
Kourosh-Arami M; Komaki A; Gholami M
Protein Pept Lett; 2023; 30(8):619-625. PubMed ID: 37409547
[TBL] [Abstract][Full Text] [Related]
19. Stress induces reinstatement of extinguished cocaine conditioned place preference by a sequential signaling via neuropeptide S, orexin, and endocannabinoid.
Chou YH; Hor CC; Lee MT; Lee HJ; Guerrini R; Calo G; Chiou LC
Addict Biol; 2021 May; 26(3):e12971. PubMed ID: 33078457
[TBL] [Abstract][Full Text] [Related]
20. Metabolic regulation of lateral hypothalamic glucose-inhibited orexin neurons may influence midbrain reward neurocircuitry.
Sheng Z; Santiago AM; Thomas MP; Routh VH
Mol Cell Neurosci; 2014 Sep; 62():30-41. PubMed ID: 25107627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
